Literature DB >> 27341411

Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.

Julio F Jiménez-Bonilla1, Ignacio Banzo, María De Arcocha-Torres, Remedios Quirce, Isabel Martínez-Rodríguez, Carmen Lavado-Pérez, Zully Bravo-Ferrer, Eloy Rodríguez-Rodríguez, Pascual Sánchez-Juan, José M Carril.   

Abstract

OBJECTIVE: Amyloid imaging clinically is usually reported as positive or negative, and the role of amyloid topography has not been studied before. To evaluate in a clinical setting the regional distribution patterns of C-Pittsburgh compound B (C-PIB) and the fluorine-18-fluorodeoxyglucose (F-FDG) uptake in patients with mild cognitive impairment (MCI), we designed this study.
METHODS: We studied 81 consecutive MCI patients, 64 amnestic (A-MCI) and 17 nonamnestic (NA-MCI) by C-PIB and F-FDG PET/computed tomography, by visual analysis. PIB retention was classified according to the regional distribution into the following patterns: A (frontal, lateral temporal, basal ganglia and anterior cingulate) and B (global retention). F-FDG images were considered positive only if temporoparietal hypometabolism consistent with Alzheimer's disease was observed.
RESULTS: In 42 of the 64 A-MCI, C-PIB was positive. Twelve of the 42 positive A-MCI showed an A-pattern, all F-FDG negative, and 30 a B-pattern, 10 F-FDG positive and 20 F-FDG negative. Of the 17 NA-MCI, C-PIB was positive in three and F-FDG was positive in one. The different proportion of C-PIB positivity in A-MCI and NA-MCI was highly significant (P<0.001).
CONCLUSION: Two different C-PIB patterns were observed in MCI patients and for the A-pattern, glucose hypometabolism consistent with Alzheimer's disease is highly unlikely. These findings may contribute towards a better selection of patients for future potential treatments and also to optimize the use of F-FDG-PET/CT.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27341411     DOI: 10.1097/MNM.0000000000000569

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

1.  The mechanism of lipopolysaccharide administration-induced cognitive function impairment caused by glucose metabolism disorder in adult rats.

Authors:  Yiri Du; Hongwei Cui; Yunfeng Xiao; Jianbo Li; Engboer Su; Zhipeng Xu; Weidong Mi
Journal:  Saudi J Biol Sci       Date:  2019-07-02       Impact factor: 4.219

2.  Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing perioperative neurocognitive disorders.

Authors:  Gang Luo; Xiaofeng Wang; Yongchen Cui; Yue Cao; Zhe Zhao; Junfeng Zhang
Journal:  J Neuroinflammation       Date:  2021-11-13       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.